Cancer Cell Models for the Development of Anti-Cancer Drugs
In the multi-factorial etiology of organ-site cancers by suspect human chemical carcinogens, oncogenic virus, activation of RAS, Myc and HER-2 oncogenes, inactivation of TP53, RB and APC tumor suppressor genes represent early-occurring genetic events [...]
Main Author: | Nitin T. Telang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/22/14457 |
Similar Items
-
Stem Cell Models for Breast and Colon Cancer: Experimental Approach for Drug Discovery
by: Nitin T. Telang
Published: (2022-08-01) -
Drug-Resistant Stem Cells: Novel Approach for Colon Cancer Therapy
by: Nitin Telang
Published: (2022-02-01) -
Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020
by: Jonas Cicenas, et al.
Published: (2021-02-01) -
Stem Cell Models for Cancer Therapy
by: Nitin Telang
Published: (2022-06-01) -
Mechanisms of Phytochemicals in Anti-Inflammatory and Anti-Cancer
by: Ji-Hoon Jang, et al.
Published: (2023-04-01)